About Vertosa
Vertosa is a company based in Oakland (United States) founded in 2013. Vertosa has raised $6 million across 2 funding rounds from investors including Döhler Ventures, WelCan Capital and AFI Capital Partners. Vertosa offers products and services including Liquid Emulsion. Vertosa operates in a competitive market with competitors including Holistic Industries, MediPharm Labs, FarmaceuticalRX, Motif Labs and ANANDA Scientific, among others.
- Headquarter Oakland, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vertosa, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Döhler Ventures
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vertosa
Vertosa offers a comprehensive portfolio of products and services, including Liquid Emulsion.
Provides stable, bioavailable emulsions for cannabis infused products.
People of Vertosa
Unlock access to complete
Funding Insights of Vertosa
Vertosa has successfully raised a total of $6M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vertosa
Vertosa has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Döhler Ventures, WelCan Capital and AFI Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups in nutrition and technology are supported.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Growth equity investments are made in hyper-growth markets by AFI Capital Partners.
|
Locked | Locked | Locked |
Investor details for Vertosa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vertosa
Investment portfolio details for Vertosa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vertosa
Detailed financials for Vertosa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vertosa Comparisons
Peer comparison for Vertosa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vertosa
Vertosa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Holistic Industries, MediPharm Labs, FarmaceuticalRX, Motif Labs and ANANDA Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary medical cannabis strains are developed and offered.
|
|
| Locked | Locked | Locked |
Pharmaceutical-grade cannabinoid products and APIs are manufactured.
|
|
| Locked | Locked | Locked |
Cannabis-based products including flower and concentrates are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Cannabinoid extraction, purification, and formulation services are provided.
|
|
| Locked | Locked | Locked |
Oral cannabis-based healthcare products are developed for therapeutic treatments.
|
Detailed competitors of Vertosa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vertosa
Complete news archive for Vertosa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vertosa
Vertosa was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Vertosa is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Ben Larson is the current CEO of Vertosa.
Vertosa is a funded company, having raised a total of $6M across 2 funding rounds to date.
The company was founded in 2013 in Oakland, United States, and operates in the cannabis technology sector. Nano- and micro-emulsions are offered for use in infused beverages, edibles, and topicals derived from hemp. Pre-suspended aqueous solutions are utilized to ensure product homogeneity and bioavailability. Services focus on enhancing flavor and clarity in cannabis-based formulations for various applications.
Vertosa's top competitors include Holistic Industries, MediPharm Labs and FarmaceuticalRX.
Vertosa offers Liquid Emulsion.
Vertosa has 7 investors. Key investors include Döhler Ventures, WelCan Capital, AFI Capital Partners, Goat Rodeo Capital, and Finn Capital Partners.